A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, has ...
Merck & Co. will apply the somatic genomics platform Quotient Therapeutics to discover novel drug targets in inflammatory bowel disease (IBD), through a collaboration that could generate up to $2.2 ...
Scientists have uncovered a surprising secret about our DNA: it’s not a static blueprint, but a constantly shifting, folding ...
A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, together ...
A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, together with collaborators ...
Morning Overview on MSN
BA.3.2 'Cicada' COVID-19 variant spreads in US.; symptoms to watch
A COVID-19 subvariant called BA.3.2, nicknamed “Cicada,” is spreading rapidly across the United States after first being detected in South Africa in November 2024. The strain carries unusual genetic ...
In the not-too-distant future, if your T-shirt starts giving fashion advice or we’re all enslaved by a race of ...
Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...
MIT Technology Review discovered that the stealth startup’s founder John Schloendorn also pitched a startling, medically ...
Morning Overview on MSN
DNA-based system targets cancer cells, a step toward smarter drugs
Researchers have built DNA-based nanodevices that can identify cancer cells, latch onto them, and deliver drugs or ...
Trace the timeline of CRISPR-Cas9 from its 2012 discovery to the latest AI-driven advancements and "N-of-1" clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results